F. J. Boswell

946 total citations
17 papers, 785 citations indexed

About

F. J. Boswell is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, F. J. Boswell has authored 17 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 13 papers in Molecular Medicine and 8 papers in Epidemiology. Recurrent topics in F. J. Boswell's work include Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). F. J. Boswell is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). F. J. Boswell collaborates with scholars based in United Kingdom and Germany. F. J. Boswell's co-authors include Robert A. Wise, J. M. Andrews, N. Brenwald, J. M. Andrews, J Woodcock, J. P. Ashby, J. Andrews, A. Dalhoff, R. Wise and Charles Fogarty and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

F. J. Boswell

17 papers receiving 724 citations

Peers

F. J. Boswell

PHARM

EPIDE

Kim Credito United States

E Huczko United States

Dianne B. Hoellman United States

Sergey N. Vostrov United States

H. A. Holt United Kingdom

Pamela R. Tessier United States

B Kolek United States

Gengrong Lin United States

Beatrice Minassian United States

J. Prieto Spain

Kim Credito United States

F. J. Boswell

308 ×0.7

PHARM

318 ×0.9

EPIDE

255 ×0.7

410 ×1.6

165 ×1.1

Citations per year, relative to F. J. Boswell F. J. Boswell (= 1×) peers Kim Credito

Countries citing papers authored by F. J. Boswell

Since Specialization

Citations

This map shows the geographic impact of F. J. Boswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. J. Boswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. J. Boswell more than expected).

Fields of papers citing papers by F. J. Boswell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. J. Boswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. J. Boswell. The network helps show where F. J. Boswell may publish in the future.

Co-authorship network of co-authors of F. J. Boswell

This figure shows the co-authorship network connecting the top 25 collaborators of F. J. Boswell. A scholar is included among the top collaborators of F. J. Boswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. J. Boswell. F. J. Boswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Boswell, F. J.. (2002). Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance. Journal of Antimicrobial Chemotherapy. 50(4). 495–502. 30 indexed citations

Boswell, F. J.. (2002). Effect of protein binding on the in vitro activity and pharmacodynamics of faropenem. Journal of Antimicrobial Chemotherapy. 50(4). 525–532. 29 indexed citations

Andrews, J. M., F. J. Boswell, & Robert A. Wise. (2000). Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique. Journal of Antimicrobial Chemotherapy. 46(4). 535–540. 20 indexed citations

Boswell, F. J., J. M. Andrews, Robert A. Wise, & A. Dalhoff. (1999). Bactericidal properties of moxifloxacin and post-antibiotic effect. Journal of Antimicrobial Chemotherapy. 43(suppl_2). 43–49. 48 indexed citations

Boswell, F. J., J. M. Andrews, & Robert A. Wise. (1998). Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time kill kinetics and postantibiotic effect. Clinical Microbiology and Infection. 4(4). 186–191. 3 indexed citations

Boswell, F. J. & Robert A. Wise. (1998). ADVANCES IN THE MACROLIDES AND QUINOLONES. Infectious Disease Clinics of North America. 12(3). 647–670. 7 indexed citations

Wise, Robert A., J. M. Andrews, F. J. Boswell, & J. P. Ashby. (1998). The in-vitro activity of linezolid (U-100766) and tentative breakpoints. Journal of Antimicrobial Chemotherapy. 42(6). 721–728. 135 indexed citations

Boswell, F. J.. (1998). Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect. Journal of Antimicrobial Chemotherapy. 41(2). 149–153. 44 indexed citations

Boswell, F. J., J. M. Andrews, J. P. Ashby, et al.. (1998). The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent. Journal of Antimicrobial Chemotherapy. 42(6). 703–709. 61 indexed citations

10.

Boswell, F. J., et al.. (1997). Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods. Journal of Antimicrobial Chemotherapy. 39(suppl 1). 29–32. 15 indexed citations

11.

Boswell, F. J., J. M. Andrews, & Robert A. Wise. (1997). Pharmacodynamic properties of faropenem demonstrated by studies of time- kill kinetics and postantibiotic effect. Journal of Antimicrobial Chemotherapy. 39(3). 415–418. 20 indexed citations

12.

Boswell, F. J., J. M. Andrews, & Robert A. Wise. (1997). Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect. Antimicrobial Agents and Chemotherapy. 41(6). 1377–1379. 35 indexed citations

13.

Boswell, F. J., J. M. Andrews, & Robert A. Wise. (1997). Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 39(6). 811–814. 15 indexed citations

14.

Woodcock, J, J. M. Andrews, F. J. Boswell, N. Brenwald, & Robert A. Wise. (1997). In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy. 41(1). 101–106. 226 indexed citations

15.

Boswell, F. J., J. M. Andrews, & R. Wise. (1996). BACTERICIDAL ACTIVITY OF TROVAFLOXACIN UNDER ANAEROBIC AND AEROBIC CONDITIONS. Infectious Diseases in Clinical Practice. 5. S113–S116. 6 indexed citations

16.

Andrews, J., et al.. (1995). The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. Journal of Antimicrobial Chemotherapy. 35(6). 869–876. 76 indexed citations

17.

Boswell, F. J., J. M. Andrews, & Robert A. Wise. (1994). The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC. Journal of Antimicrobial Chemotherapy. 33(6). 1219–1222. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact